Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2

被引:38
|
作者
Kukongviriyapan, V [1 ]
Phromsopha, N
Tassaneeyakul, W
Kukongviriyapan, U
Sripa, B
Hahnvajanawong, V
Bhudhisawasdi, V
机构
[1] Khon Kaen Univ, Fac Med, Dept Pharmacol, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, Fac Med, Dept Physiol, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen 40002, Thailand
[3] Khon Kaen Univ, Fac Med, Dept Pathol, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen 40002, Thailand
[4] Khon Kaen Univ, Fac Med, Dept Surg, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen 40002, Thailand
[5] Khon Kaen Univ, Fac Sci, Dept Chem, Khon Kaen 40002, Thailand
关键词
arylamine N-acetyltransferase; phytochemicals; polyphenol; flavonoids; quercetin; curcumin;
D O I
10.1080/00498250500489901
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Arylamine N-acetyltransferases (NAT) are important enzymes involved in the metabolic activation of aromatic and heterocyclic amines and inhibitors of NAT enzymes may be valuable as chemopreventive agents. Phytochemicals including cinnamic acid derivatives, various classes of flavonoids and coumarins were tested for the inhibitory activity on NAT1 and NAT2 from human liver and the human cholangiocarcinoma cell line: KMBC cells. Assays were performed using p-aminobenzoic acid and sulfamethazine as selective substrates for NAT1 and NAT2, respectively. NAT1 and NAT2 activities were present in liver cytosol. However, the KMBC cells showed only NAT1 activity. There was a marked difference in the ability of the test chemicals to inhibit NAT1 and NAT2. Caffeic acid, ferulic acid, gallic acid and EGCG inhibited NAT1 but not NAT2, whereas scopuletin and curcumin inhibited NAT2 but not NAT1. Quercetin, kaemferol and other flavonoids, except epicatechin and silymarin, inhibited both enzymes. The kinetics of inhibition of NAT1 by caffeic acid, EGCG and quercetin were of the non-competitive type, whereas that of NAT2 by quercetin, curcumin and kaemferol was also of the non-competitive type. The most potent inhibitor was quercetin, which has the inhibitory constants for NAT1 and NAT2 of 48.6 +/- 17.3 and 10.0 +/- 1.8 mu M, respectively.
引用
收藏
页码:15 / 28
页数:14
相关论文
共 50 条
  • [1] Expression and purification of human arylamine N-acetyltransferase 2
    Baker, Inesha
    Hurlbert, Jason
    Parker, Chasta L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 771 - 771
  • [2] ARYLAMINE N-ACETYLTRANSFERASE
    SIM, E
    HICKMAN, D
    CORONEOS, E
    KELLY, SL
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1992, 20 (02) : 304 - 309
  • [3] Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
    Nicola Laurieri
    Akane Kawamura
    Isaac M Westwood
    Amy Varney
    Elizabeth Morris
    Angela J Russell
    Lesley A Stanley
    Edith Sim
    BMC Pharmacology and Toxicology, 15
  • [4] ARYLAMINE N-ACETYLTRANSFERASE ACTIVITY OF THE HUMAN PLACENTA
    DEREWLANY, LO
    KNIE, B
    KOREN, G
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (02): : 756 - 760
  • [5] Expression of arylamine N-acetyltransferase in human intestine
    Hickman, D
    Pope, J
    Patil, SD
    Fakis, G
    Smelt, V
    Stanley, LA
    Payton, M
    Unadkat, JD
    Sim, E
    GUT, 1998, 42 (03) : 402 - 409
  • [6] Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
    Laurieri, Nicola
    Kawamura, Akane
    Westwood, Isaac M.
    Varney, Amy
    Morris, Elizabeth
    Russell, Angela J.
    Stanley, Lesley A.
    Sim, Edith
    BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [7] Interaction of Human Arylamine N-Acetyltransferase 1 with Different Nanomaterials
    Deng, Zhou J.
    Butcher, Neville J.
    Mortimer, Gysell M.
    Jia, Zhongfan
    Monteiro, Michael J.
    Martin, Darren J.
    Minchin, Rodney F.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (03) : 377 - 383
  • [8] Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes
    Mitchell, KR
    Warshawsky, D
    TOXICOLOGY LETTERS, 2003, 139 (01) : 11 - 23
  • [9] Arylamine N-acetyltransferase I
    Minchin, Rodney F.
    Hanna, Patrick E.
    Dupret, Jean-Marie
    Wagner, Carston R.
    Rodrigues-Lima, Fernando
    Butcher, Neville J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (11): : 1999 - 2005
  • [10] Kinetic characterization of arylamine N-acetyltransferase 2
    Baker, Inesha
    Parker, Chasta L.
    FASEB JOURNAL, 2008, 22